Application made for group claim seeking compensation for companies for alleged overcharging on customer card payments Visa and Mastercard are being threatened with a potential £5bn lawsuit for allegedly stifling competition and charging UK businesses excessive fees. The law firms Harcus Parker and Hausfeld have lodged an application at the Competition Appeal Tribunal in hopes of pursuing a group claim that would compensate companies who, they claim, have been overcharged on customer card payments since October 2020. Continue reading...
Visa and Mastercard threatened with potential £5bn UK lawsuit over fees
Source: The Guardian
Original reporting
The Guardian: read the full reportRelated stories
CNBC
Oil ticks lower as Saudi defense minister meets with Iran's president in Tehran to de-escalate
Investors are worried about the vulnerability of Saudi energy infrastructure and the risk of another disruption to production, refining or export facilities.
CNBC
Trump DOJ unlawfully fired Epstein prosecutor Maurene Comey, judge rules
The judge ordered that Comey, the daughter of ex-FBI director James Comey, be retroactively reinstated to her job as an assistant United States attorney.
CNBC
Lula wins Brazil runoff after prediction markets favored Bolsonaro
While prediction market odds pointed to a clear Bolsonaro victory, Lula emerged the winner in a tight race.
CNBC3 outlets
Microsoft offers voluntary buyouts to 60,000 employees as AI leads to efficiency push
Microsoft is offering voluntary buyouts to up to 60,000 employees across the US, UK, Canada, and India. In a message to employees, Microsoft chief people officer Amy Coleman writes that this gives staff members "the opportunity to leave Microsoft with financial support and career planning resources" as the company looks to trim staff without another […]
BBC Business2 outlets
Anthropic's blockbuster share listing - 5 surprising things we now know
Anthropic’s IPO prospectus is 355 pages and full of never before disclosed company information.
CNBC
Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.